Moderna Surges on Cancer Vaccine Breakthrough

Moderna shares surged 101% following positive trial results showing its personalized cancer vaccine combined with Merck's Keytruda significantly reduced melanoma recurrence and tumor spread. Estee Lauder rallied after beating earnings expectations and providing forward guidance above Street views. La-Z-Boy declined after missing Q2 sales forecasts.